Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Melphalan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 77,749Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Delcath Reports Inducement Grants Under Nasdaq Rule
    Delcath Reports Inducement Grants Under Nasdaq Rule

    20 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240920159715/en

    BUSINESSWIRE
    20 Sep 2024
    Share Share
    Delcath Presents HEPZATO KIT Data At ESMO 2024
    Delcath Presents HEPZATO KIT Data At ESMO 2024

    16 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240916710391/en

    BUSINESSWIRE
    16 Sep 2024
    Share Share
    Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
    Delcath Systems Reports Second Quarter 2024 Results and Business Highlights

    05 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240805008997/en

    BUSINESSWIRE
    05 Aug 2024
    Share Share
    Delcath Systems to Host Second Quarter 2024 Earnings Call
    Delcath Systems to Host Second Quarter 2024 Earnings Call

    22 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240722726409/en

    BUSINESSWIRE
    22 Jul 2024
    Share Share
    Casi Pharma RenewsExclusive Distribution Agreement For Evomela
    Casi Pharma RenewsExclusive Distribution Agreement For Evomela

    04 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-renewal-of-exclusive-distribution-agreement-for-evomela-in-china-301495624.html

    PRNEWSWIRE
    04 Mar 2022
    Share Share
    TAK1 blocker teams up with chemo to kill myeloma cells: study
    TAK1 blocker teams up with chemo to kill myeloma cells: study

    18 Oct 2021

    // Arlene Weintraub FIERCEBIOTECH

    https://www.fiercebiotech.com/research/a-new-target-multiple-myeloma-tak1-blocker-boosts-chemo-s-cancer-killing-power-preclinical

    Arlene Weintraub FIERCEBIOTECH
    18 Oct 2021
    Share Share